Nippon India Nifty Pharma Etf Datagrid
Category Other ETFs
BMSMONEY Rank 72
Rating
Growth Option 04-12-2025
NAV ₹23.52(R) +0.23% (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 2.9% 21.31% -% -% -%
Direct
Benchmark
SIP (XIRR) Regular 11.01% 19.16% -% -% -%
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.72 0.39 0.74 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
17.0% -18.91% -15.21% - 11.79%
Fund AUM As on: 30/06/2025 917 Cr

NAV Date: 04-12-2025

Scheme Name NAV Rupee Change Percent Change
Nippon India Nifty Pharma ETF 23.52
0.0500
0.2300%

Review Date: 04-12-2025


Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.79
2.39
-7.41 | 21.17 31 | 184 Very Good
3M Return % 4.73
7.30
-3.16 | 43.69 107 | 184 Average
6M Return % 7.83
9.81
-8.69 | 74.64 41 | 184 Very Good
1Y Return % 2.90
10.22
-17.36 | 94.42 135 | 183 Average
3Y Return % 21.31
16.17
0.00 | 54.40 27 | 139 Very Good
1Y SIP Return % 11.01
20.99
-13.00 | 144.84 117 | 183 Average
3Y SIP Return % 19.16
16.32
0.00 | 53.54 31 | 139 Very Good
Standard Deviation 17.00
14.08
0.00 | 37.03 87 | 118 Average
Semi Deviation 11.79
10.08
0.00 | 23.59 80 | 118 Average
Max Drawdown % -15.21
-15.83
-33.49 | 0.00 55 | 118 Good
VaR 1 Y % -18.91
-17.07
-36.63 | 0.00 66 | 118 Average
Average Drawdown % -7.67
-7.24
-16.08 | 0.00 57 | 118 Good
Sharpe Ratio 0.72
0.07
-86.31 | 2.51 53 | 116 Good
Sterling Ratio 0.74
0.68
0.00 | 2.32 39 | 118 Good
Sortino Ratio 0.39
0.41
-1.00 | 1.94 49 | 118 Good
Return data last Updated On : Dec. 4, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 17.00 14.08 0.00 | 37.03 87 | 118 Average
Semi Deviation 11.79 10.08 0.00 | 23.59 80 | 118 Average
Max Drawdown % -15.21 -15.83 -33.49 | 0.00 55 | 118 Good
VaR 1 Y % -18.91 -17.07 -36.63 | 0.00 66 | 118 Average
Average Drawdown % -7.67 -7.24 -16.08 | 0.00 57 | 118 Good
Sharpe Ratio 0.72 0.07 -86.31 | 2.51 53 | 116 Good
Sterling Ratio 0.74 0.68 0.00 | 2.32 39 | 118 Good
Sortino Ratio 0.39 0.41 -1.00 | 1.94 49 | 118 Good
Return data last Updated On : Dec. 4, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2025
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Nippon India Nifty Pharma Etf NAV Regular Growth Nippon India Nifty Pharma Etf NAV Direct Growth
04-12-2025 23.5185 None
03-12-2025 23.4663 None
02-12-2025 23.4635 None
01-12-2025 23.4459 None
28-11-2025 23.5596 None
27-11-2025 23.4212 None
26-11-2025 23.4206 None
25-11-2025 23.1428 None
24-11-2025 23.0421 None
21-11-2025 23.1331 None
20-11-2025 23.2424 None
19-11-2025 23.2836 None
18-11-2025 23.2694 None
17-11-2025 23.4272 None
14-11-2025 23.3799 None
13-11-2025 23.2425 None
12-11-2025 23.147 None
11-11-2025 22.918 None
10-11-2025 22.9286 None
07-11-2025 22.7105 None
06-11-2025 22.7934 None
04-11-2025 22.8795 None

Fund Launch Date: 02/Jul/2021
Fund Category: Other ETFs
Investment Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Description: An open ended scheme replicating/ tracking NIFTY Pharma Index
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.